Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program partnership. | Pfizer and Flagship Pioneering are turning to autoimmune ...

Pfizer and Flagship will engage Charles River Laboratories to leverage Logica, an artificial intelligence (AI)-powered ...

One of the most promising aspects of AI and its integration into the pharmaceutical industry is the technology’s potential to ...

Collaboration leverages Logica, a platform offering from Valo Health and Charles ... signed under strategic partnership between Flagship Pioneering and Pfizer to accelerate discovery of ...

Pfizer (PFE) and Pioneering Medicines, Flagship Pioneering’s in-house drug discovery and development unit, announced an agreement to discover ...

Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and cardiometabolic diseases, leveraging AI and extensive human datasets.

Novo Nordisk gets a license to three preclinical-stage cardiovascular disease programmes from Valo Health in return for its initial investment and is prepared to expand the partnership to cover 11 ...

CAMBRIDGE, Mass. & LEXINGTON, Mass., March 18, 2025--(BUSINESS WIRE)--Valo Health, Inc. ("Valo"), a biotechnology company focused on transforming the drug discovery and development process using ...

Valo Health, Inc. (“Valo”), a biotechnology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence (AI), today ...